Platform
Consulting
Resources
Pricing
EUP OHAMR Joint Transnational Call - Canada
Closed

EUP OHAMR Joint Transnational Call

Supports One Health research on antimicrobial resistance treatment innovations
Canadian Institutes of Health Research (CIHR)
Last Update: March 4, 2026
Funding available
$ 600,000
Timeline
  • Closing date : February 24, 2026
Location
Canada

Overview

This CIHR Operating Grant supports a Canadian component of a joint transnational One Health antimicrobial resistance project to advance innovative, cost-effective AMR treatment options, with up to Can$600,000 total (Can$200,000 per year for up to 3 years). Eligible activities must address Topic 3 by assessing how veterinary and agricultural use of antibacterial and antifungal drugs affects AMR emergence and transmission to humans and the environment, and improving formulations, dosage, delivery, routes of administration, and treatment regimens to inform policies restricting certain antimicrobials for exclusive human use.
/100
Opportunity Score
Moderate potential, but conditions must align.

At a glance

Funding available

Financing goals
  • Develop strategic partnerships
  • Conduct research and development activities
  • Conduct research or evaluation activities
Eligible Funding
  • Maximum amount : 600,000 $
Timeline
  • Closing date : February 24, 2026

Eligible candidates

Eligible Industries
  • Agriculture, forestry, fishing and hunting
  • Professional, scientific and technical services
  • Health care and social assistance
Location
  • Canada
Legal structures
  • Non-profit
  • Public or Parapublic institution
Annual revenue
  • All revenue ranges
Organisation size
  • All organization sizes
Audience
  • Indigenous Peoples
  • Canadians
Non-profit candidates
Sector of operation
  • All industries
Target groups
  • All the groups
Revenue structures
  • All structures
Scope
  • All dimensions

Next steps

1
Determine your project
2
Validate your eligibility

Activities funded

  • Joint transnational One Health research projects that advance innovative, cost-effective antimicrobial resistance (AMR) treatment options and include human health research activities.
  • Research assessing how veterinary and agricultural use of antibacterial and antifungal drugs (e.g., mechanisms of action, formulations, routes of administration, and treatment regimens) affects the emergence and transmission of AMR to humans and the environment.
  • Projects aimed at improving veterinary/agricultural antimicrobial formulation, dosage, delivery, routes of administration, and treatment regimens (including pharmacokinetics/pharmacodynamics) to reduce cross-resistance or AMR transmission to humans and the environment.
  • Research generating evidence to inform policies that restrict certain antimicrobials for exclusive human use.

Documents Needed

  • One-page Research Project Summary
  • Copy of the EUP OHAMR pre-proposal submitted to the Joint Call Secretariat
  • Operating budget (in CAD) with justification (for the CIHR abbreviated application stage)
  • Copy of the EUP OHAMR full proposal submitted to the Joint Call Secretariat
  • Certificate of completion for the CIHR sex- and gender-based analysis (SGBA) training (Nominated Principal Applicant)

Eligibility

Who is eligible?

  • Indigenous non-governmental organizations (Indigenous NGOs) in Canada with a mandate for research or knowledge mobilization.
  • Non-profit organizations (e.g., hospitals, research institutes, or other organizations) with a mandate for health research or knowledge mobilization, affiliated with a Canadian postsecondary institution.

Who is not eligible

  • For-profit companies (the Nominated Principal Applicant must be an independent researcher affiliated with a Canadian postsecondary institution/affiliated institution, or affiliated with/being an Indigenous non-governmental organization with a research and/or knowledge translation mandate).
  • Organizations or projects focused only on animal health, plants, food and/or the environment without including human health research activities (CIHR will not fund these).
  • Applicants/projects that do not address the required call topic for CIHR funding (Topic 3); proposals outside this topic will not be deemed relevant and will not receive CIHR funding.

Eligible geographic areas

  • Canada (Nominated Principal Applicant must have their substantive role in Canada for the duration of the grant term).

Processing and Agreement

  • Proposals are evaluated through the EUP OHAMR review and evaluation process (see the EUP OHAMR call for details).
  • CIHR performs an additional relevance review using the full application to confirm alignment with CIHR’s mandate, Topic 3, and human health.
  • Funding decisions follow the process set out by EUP OHAMR (see the EUP OHAMR call for details).
  • Applicants are notified according to the posted timelines (anticipated decisions: April 30, 2026 for the pre-proposal stage; October 30, 2026 for the full proposal stage).
  • The names of successful funded applicants are published on the CIHR website.

Additional information

  • Pre-proposals and full proposals to EUP OHAMR must be submitted to the Joint Call Secretariat no later than 13:00 (CET).
  • The Joint Call Secretariat will host a webinar on November 26, 2025 to support participants with call requirements and questions.
  • CIHR is providing a Partner Linkage Tool to facilitate connections between researchers and potential partners (e.g., government, NGOs, community-based organizations).
  • This funding opportunity content was updated on January 16, 2026 (Review Process and Evaluation section).

Contacts

secretariat@ohamr.eu
+46 8 546 44 000

Frequently Asked Questions about the EUP OHAMR Joint Transnational Call Program

Here are answers to the most common questions about the EUP OHAMR Joint Transnational Call. This section explains what the program is, how much funding is available, eligibility requirements, application deadlines, and other important details to help you determine if this grant is right for your business.

What is the EUP OHAMR Joint Transnational Call?

This CIHR Operating Grant supports a Canadian component of a joint transnational One Health antimicrobial resistance project to advance innovative, cost-effective AMR treatment options, with up to Can$600,000 total (Can$200,000 per year for up to 3 years). Eligible activities must address Topic 3 by assessing how veterinary and agricultural use of antibacterial and antifungal drugs affects AMR emergence and transmission to humans and the environment, and improving formulations, dosage, delivery, routes of administration, and treatment regimens to inform policies restricting certain antimicrobials for exclusive human use.

How much funding can be received?

EUP OHAMR Joint Transnational Call Funds up to $600,000 of admissible expenses.

Who is eligible for the EUP OHAMR Joint Transnational Call program?

To be eligible for the EUP OHAMR Joint Transnational Call program, you must: Applicant must be an Indigenous non-governmental organization in Canada with a research and/or knowledge translation mandate. The Institution Paid must be CIHR-authorized to receive/administer funds. Must meet EUP OHAMR eligibility criteria (OH-TREAT call).

What expenses are eligible under EUP OHAMR Joint Transnational Call?

Joint transnational One Health research projects that advance innovative, cost-effective antimicrobial resistance (AMR) treatment options and include human health research activities. Research assessing how veterinary and agricultural use of antibacterial and antifungal drugs (e.g., mechanisms of action, formulations, routes of administration, and treatment regimens) affects the emergence and transmission of AMR to humans and the environment. Projects aimed at improving veterinary/agricultural antimicrobial formulation, dosage, delivery, routes of administration, and treatment regimens (including pharmacokinetics/pharmacodynamics) to reduce cross-resistance or AMR transmission to humans and the environment. Research generating evidence to inform policies that restrict certain antimicrobials for exclusive human use.

Who can I contact for more information about the EUP OHAMR Joint Transnational Call?

You can contact Canadian Institutes of Health Research (CIHR) by email at secretariat@ohamr.eu or by phone at +46 8 546 44 000.

Where is the EUP OHAMR Joint Transnational Call available?

The EUP OHAMR Joint Transnational Call program is available across Canada.

Is the EUP OHAMR Joint Transnational Call a grant, loan, or tax credit?

EUP OHAMR Joint Transnational Call is a Grant and Funding

More programs like this